Health4 months ago
Gilead’s Lenacapavir-Bictegravir Pill Achieves Milestone in Phase 3 Trial
A fixed-dose combination pill developed by Gilead Sciences has successfully met its primary endpoint in a Phase 3 clinical trial. The ARTISTRY-2 trial results indicate that...
